#55 Prevalence, symptom bother, and healthcare seeking among individuals with overactive bladder: results from the EPIC study
Milsom I1, Irwin D2, Reilly K3, Coyne K S4, Hunskaar S5, Kopp Z3, Herschorn S6, Kelleher C7, Hampel C8, Artibani W9, Abrams P10 1. Sahlgrenska Academy at Goteborg University, 2. University of North Carolina, Chapel Hill, 3. Pfizer, Inc, 4. United BioSource Corporation, 5. University of Bergen, Norway, 6. University of Toronto, 7. St. Thomas' Hospital, London, 8. Johannes-Gutenberg-Universität, 9. University of Padova, 10. Southmead Hospital, Bristol Urological Institute
#56 PATIENT SATISFACTION IN STUDIES OF OVERACTIVE BLADDER: A GENERIC QUESTIONNAIRE VERSUS A DISEASE SPECIFIC QUESTIONNAIRE
Kopp Z1, Abrams P2, Piault E3, Evans C3, Espindle D3, Atkinson M1, Brubaker L4, Jumadilova Z1 1. Pfizer, Inc, 2. Southmead Hospital, Bristol Urological Institute, 3. Mapi Values, 4. Loyola University Medical Center
#57 Is there a Discrepancy between Patient and Physician Quality of Life Assessment?
Srikrishna S1, Robinson D1, Cardozo L1, Balmforth J1, Gonzalez J1 1. Kings College Hospital
#58 Do colour and personality influence treatment seeking behaviour in women with lower urinary tract dysfunction?
Basra R1, Cortes E1, Khullar V2, Kelleher C1 1. Guys & St Thomas NHS Foundation Trust, 2. St Mary's NHS Trust